53 phd-rehabilitation-engineering-computer-science Fellowship positions at University of Birmingham in United Kingdom
Sort by
Refine Your Search
-
Summary Work within the PRE-EMPT programme grant and its team of co-applicants Operate within area of specialism (implementation science/behaviour change/maternal health) Analyse and interpret data and
-
: 21st August 2025 Background To create and contribute to the creation of knowledge by undertaking advanced analysis and validation experiments within the MRC BioFlare research programme: Although outcomes
-
Job Description Position Details Department of Nursing and Midwifery, School of Health Sciences, College of Medicine and Health Location: University of Birmingham, Edgbaston, Birmingham UK Full time
-
Sciences, University of Birmingham, led by Dr Rebecca Drummond. We are looking for an enthusiastic and committed scientist to join our project team, which is aiming to better understand the in-host behaviour
-
Sciences, University of Birmingham, led by Dr Rebecca Drummond. We are looking for an enthusiastic and committed scientist to join our project team, which is aiming to better understand the in-host behaviour
-
for publication, research seminars etc Supervise students on research related work and provide guidance to PhD students where appropriate to the discipline Contribute to developing new models, techniques and
-
strive to integrate structural biology with functional studies in cells and whole organisms, as well as with drug design and molecular engineering. If you are curious, motivated and ready for challenge
-
and provide guidance to PhD students where appropriate to the discipline Contribute to developing new models, techniques and methods Undertake management/administration arising from research Contribute
-
are required to hold the following qualifications: A Bachelors or Masters degree, ideally in a relevant STEM discipline (eg. Biological sciences). A PhD (or near to completion) in a field relevant to the project
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor